Pontifax Founded 2004
Founders Ran Nussbaum Tomer Kariv
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 36
Average round size
info
The average size of a deal this fund participated in
$30M
Portfolio companies 36
Rounds per year 2.12
Lead investments 10
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.25
Exits -
Key employees -
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity
Areas of investment
Biotechnology
Medical Device
Pharmaceutical
Venture Capital
Summary

Pontifax appeared to be the VC, which was created in 2004. The main department of described VC is located in the Herzliya. The fund was located in Asia if to be more exact in Israel.

The important activity for fund was in 2017. The usual things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 7 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this Pontifax performs on 4 percentage points less the average number of lead investments. The fund is generally included in 2-6 deals every year. The increased amount of exits for fund were in 2019.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - Israel. The fund has specific favorite in a number of founders of portfolio startups. In case when startup counts 4 of the founder, the chance for it to get the investment is meager. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight 89bio, Dynacure, Check-Cap. Among the most successful fund investment fields, there are Pharmaceutical, Health Care.

This organization was formed by Ran Nussbaum, Tomer Kariv. The overall number of key employees were 10.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Pontifax, startups are often financed by OrbiMed, Ziegler Meditech Equity Partners, Perceptive Advisors. The meaningful sponsors for the fund in investment in the same round are Docor International Management, Quark Venture, Triventures. In the next rounds fund is usually obtained by Yissum Technology Transfer Company of the Hebrew University, Docor International Management, Clal Biotechnology Industries.

Read more
Latest deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
Alizé Pharma
Biotechnology
Health Care
Medical
Pharmaceutical
Wellness
Series A
67M31 Jul 2019 France, Écully
V-Wave
Biotechnology
Health Care
Medical
Medical Device
Series B
28M11 Jan 2016
TargEDys
Biotechnology
Health Care
Medical Device
Series A
3M12 Apr 2017 France, Saulx-les-Chartreux
TargEDys
Biotechnology
Health Care
Medical Device
Series A
6M14 Apr 2016 France, Saulx-les-Chartreux
Nutrinia
Biotechnology
Developer Tools
Health Care
Information Technology
Series D
30M18 Aug 2016 Israel, Ramat Gan
Adicet Bio
Biopharma
Biotechnology
Health Care
Medical
Series A
51M27 Jan 2016 United States, Menlo Park
Nutrinia
Biotechnology
Developer Tools
Health Care
Information Technology
Series C
12M08 Dec 2014 Israel, Ramat Gan
cCAM Biotherapeutics
Biotechnology
Clinical Trials
Therapeutics
Series A
15 Sep 2012 Israel, Kiryat Shmona
LogicBio Therapeutics
Biotechnology
Genetics
Series B
45M29 Jun 2017 United States, Foster City
Tisbury Pharmaceuticals
Clinical Trials
Health Care
Medical
Pharmaceutical
Series A
32M07 Jun 2017 United States, Beverly
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Pontifax?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: